1H-Azepine → 4-[2-(2-Azepan-1-yl-ethyl)-benzofuran-5-yl]-benzonitrile

반응식

CS(O[CH2:6][CH2:7][C:8]1[O:9][C:10]2[CH:16]=[CH:15][C:14]([C:17]3[CH:22]=[CH:21][C:20]([C:23]#[N:24])=[CH:19][CH:18]=3)=[CH:13][C:11]=2[CH:12]=1)(=O)=O.[NH:25]1[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=[CH:26]1>>[N:25]1([CH2:6][CH2:7][C:8]2[O:9][C:10]3[CH:16]=[CH:15][C:14]([C:17]4[CH:22]=[CH:21][C:20]([C:23]#[N:24])=[CH:19][CH:18]=4)=[CH:13][C:11]=3[CH:12]=2)[CH2:31][CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]1

참가 물질

반응물 2

HCID 64514761H-Azepine

HCID 113936782-[5-(4-cyanophenyl)-1-benzofuran-2-yl]ethyl Methanesulfonate

생성물 1

HCID 99027194-[2-(2-Azepan-1-yl-ethyl)-benzofuran-5-yl]-benzonitrile

실험 절차

The product from Example 1C and azepine were processed as described in Example 1D to provide the titled compound. MS (DCI) m/z 345 (M+H)+;

출처 및 근거

ORD 기록: ord-896c9e82020d440389463903cb0f010a
출처 데이터셋: uspto-grants-2005_11
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US06969730B2

반응 노트

불러오는 중…